Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion evidence source_evidence_literature NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion SIO_000772 18602826 NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion wasDerivedFrom befree-20150227 NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_assertion wasGeneratedBy ECO_0000203 NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP346780.RAbVQbovX2fSnqmsrLGzGLBADEls1rBxwkFNGs8cBGOVk130_provenance.